Richard Cate
13Patents
7h-index
17Co-inventors
63Inventor score
Filing activity: Oct 30, 1985 → Sep 23, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5109124A | Nucleic acid probe linked to a label having a terminal cysteine | Human Necessities | 215 | Expired |
| US6664385B1 | Kidney injury-related molecules | Chemistry; Metallurgy | 42 | Expired |
| US6861509B1 | Antibodies to Ret and RetL3 | Chemistry; Metallurgy | 27 | Expired |
| US5545723A | Muteins of IFN-.beta. | Human Necessities | 19 | Expired |
| US6677135B1 | Ret ligand (RetL) for stimulating neutral and renal growth | Chemistry; Metallurgy | 15 | Expired |
| US5047336A | DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides | Human Necessities | 12 | Expired |
| US7173118B2 | Nogo receptor homologs | Physics | 7 | Expired |
| US6127332A | Muteins of IFN-.beta. | Human Necessities | 7 | Expired |
| US5359033A | Cleaved dimers of mullerian inhibiting substance-like polypeptides | Human Necessities | 3 | Expired |
| US7456255B2 | Nogo receptor homologs that decrease inhibition of axonal elongation | Physics | 3 | Active |
| US5427780A | Composition comprising Mullerian inhibiting substance-like polypeptides | Chemistry; Metallurgy | 2 | Expired |
| US10774142B2 | Anti-mullerian hormone (AMH) neutralizing antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9856307B2 | Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.